FDA warns of Adderall shortage after Teva manufacturing delay
Teva Shareholder Notice
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down